| Uterine Corpus Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived159 of 159show fewer |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 108 trials (42 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 108 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 83 trials (33 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 71 trials (42 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 62 trials (19 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 38 trials (14 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 36 trials (17 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 23 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 23 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 23 trials (12 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Megestrolsmall molecule 19 trials (8 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 17 trials (8 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 16 trials (8 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 15 trials (13 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 12 trials (9 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Relugolixsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ridaforolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trabectedinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elacestrantsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imlunestrantsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inavolisibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pilaralisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Samotolisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apitolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aromatase Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camizestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyproterone Acetatesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rezatapoptsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotorasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Deruxtecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |